Vertex reports Alyftrek may reverse pancreatic insufficiency in young CF patients

October 9, 2026 1:15 PM

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) presented interim data at the North American Cystic Fibrosis Conference showing that its drug Alyftrek ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found